Pulse Biosciences Stock Price, News & Analysis (NASDAQ:PLSE)

$18.25 -0.29 (-1.56 %)
(As of 02/22/2018 04:00 PM ET)
Previous Close$18.54
Today's Range$18.19 - $18.91
52-Week Range$9.81 - $39.50
Volume17,776 shs
Average Volume88,902 shs
Market Capitalization$305.74 million
P/E Ratio-13.13
Dividend YieldN/A
Beta-0.17

About Pulse Biosciences (NASDAQ:PLSE)

Pulse Biosciences logoPulse Biosciences, Inc., formerly Electroblate, Inc., is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. NPES provides treatment in a range of dermatology and aesthetic applications. It offers treatment for minimally invasive applications, such as cardiac ablation, lung disease, Barret's esophagus, thyroid nodules, and ear, nose and throat (ENT) papillomas. The Company is developing a system for the delivery of NPES treatments, identified as the PulseTx system (PulseTx). The PulseTx system delivers NPES pulses through its tunable pulse generator and its planned suite of electrodes. The PulseTx system pulses are applied directly to tissue through electrodes, creating transient nanometer pores in cell and organelle membranes.

Receive PLSE News and Ratings via Email

Sign-up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PLSE
CUSIPN/A
Phone510-906-4600

Debt

Debt-to-Equity RatioN/A
Current Ratio17.23%
Quick Ratio17.23%

Price-To-Earnings

Trailing P/E Ratio-13.1294964028777
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$1.90 per share
Price / Book9.61

Profitability

Trailing EPS($1.39)
Net Income$-9,510,000.00
Net MarginsN/A
Return on Equity-62.10%
Return on Assets-57.47%

Miscellaneous

Employees13
Outstanding Shares16,340,000

Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences Inc (NASDAQ:PLSE) issued its earnings results on Tuesday, November, 7th. The company reported ($0.52) earnings per share (EPS) for the quarter. View Pulse Biosciences' Earnings History.

When will Pulse Biosciences make its next earnings announcement?

Pulse Biosciences is scheduled to release their next quarterly earnings announcement on Monday, March, 12th 2018. View Earnings Estimates for Pulse Biosciences.

Are investors shorting Pulse Biosciences?

Pulse Biosciences saw a decrease in short interest in the month of January. As of January 12th, there was short interest totalling 1,461,151 shares, a decrease of 5.6% from the December 29th total of 1,547,205 shares. Based on an average daily trading volume, of 71,243 shares, the short-interest ratio is presently 20.5 days. Currently, 31.0% of the company's shares are short sold.

Who are some of Pulse Biosciences' key competitors?

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company acted as the underwriters for the IPO.

Who owns Pulse Biosciences stock?

Pulse Biosciences' stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (3.02%), Citadel Advisors LLC (2.07%), TIAA CREF Investment Management LLC (0.13%), Deutsche Bank AG (0.12%), Millennium Management LLC (0.08%) and Alliancebernstein L.P. (0.06%). Company insiders that own Pulse Biosciences stock include Maky Zanganeh, Mitchell E Levinson, Robert J Greenberg, Robert W Duggan and Thierry B Thaure. View Institutional Ownership Trends for Pulse Biosciences.

Who sold Pulse Biosciences stock? Who is selling Pulse Biosciences stock?

Pulse Biosciences' stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc. and TIAA CREF Investment Management LLC. Company insiders that have sold Pulse Biosciences company stock in the last year include Robert J Greenberg and Thierry B Thaure. View Insider Buying and Selling for Pulse Biosciences.

Who bought Pulse Biosciences stock? Who is buying Pulse Biosciences stock?

Pulse Biosciences' stock was acquired by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Millennium Management LLC, Deutsche Bank AG, Alliancebernstein L.P., Brown Advisory Inc., Fore Capital LLC, The Manufacturers Life Insurance Company and Ladenburg Thalmann Financial Services Inc.. Company insiders that have bought Pulse Biosciences stock in the last two years include Maky Zanganeh, Mitchell E Levinson and Robert W Duggan. View Insider Buying and Selling for Pulse Biosciences.

How do I buy Pulse Biosciences stock?

Shares of Pulse Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pulse Biosciences' stock price today?

One share of Pulse Biosciences stock can currently be purchased for approximately $18.25.

How big of a company is Pulse Biosciences?

Pulse Biosciences has a market capitalization of $305.74 million. The company earns $-9,510,000.00 in net income (profit) each year or ($1.39) on an earnings per share basis. Pulse Biosciences employs 13 workers across the globe.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]


MarketBeat Community Rating for Pulse Biosciences (PLSE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  88 (Vote Underperform)
Total Votes:  179
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pulse Biosciences (NASDAQ:PLSE) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Pulse Biosciences (NASDAQ:PLSE) Earnings History and Estimates Chart

Earnings by Quarter for Pulse Biosciences (NASDAQ:PLSE)

Pulse Biosciences (NASDAQ PLSE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/12/2018N/AView Earnings Details
11/7/2017Q3 2017($0.52)ViewN/AView Earnings Details
7/27/2017Q2 2017($0.43)ViewN/AView Earnings Details
5/4/2017Q2 2017($0.23)ViewListenView Earnings Details
3/14/2017Q4 2016($0.21)ViewN/AView Earnings Details
11/14/2016Q3 2016($0.21)ViewN/AView Earnings Details
8/10/2016Q2 2016($0.23)ViewN/AView Earnings Details
6/27/2016Q1 2016($0.22)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Pulse Biosciences (NASDAQ:PLSE) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Pulse Biosciences (NASDAQ:PLSE)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Pulse Biosciences (NASDAQ PLSE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.70%
Institutional Ownership Percentage: 11.55%
Insider Trades by Quarter for Pulse Biosciences (NASDAQ:PLSE)
Institutional Ownership by Quarter for Pulse Biosciences (NASDAQ:PLSE)

Pulse Biosciences (NASDAQ PLSE) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2017Maky ZanganehDirectorBuy4,000$23.07$92,280.00332,500View SEC Filing  
10/19/2017Robert W DugganMajor ShareholderBuy22,901$22.79$521,913.795,820,513View SEC Filing  
9/24/2017Robert W DugganMajor ShareholderBuy2,000,000$15.02$30,040,000.005,797,612View SEC Filing  
9/18/2017Maky ZanganehDirectorBuy29,775$13.36$397,794.00315,725View SEC Filing  
9/18/2017Robert W DugganMajor ShareholderBuy409,918$14.36$5,886,422.483,437,994View SEC Filing  
9/14/2017Mitchell E LevinsonDirectorBuy3,835$12.30$47,170.50View SEC Filing  
8/3/2017Maky ZanganehDirectorBuy28,790$23.96$689,808.40287,225View SEC Filing  
8/3/2017Robert W DugganMajor ShareholderBuy277,450$23.14$6,420,193.003,153,234View SEC Filing  
8/2/2017Maky ZanganehDirectorBuy8,290$25.15$208,493.50287,225View SEC Filing  
5/23/2017Robert W DugganMajor ShareholderBuy83,928$26.86$2,254,306.083,054,244View SEC Filing  
5/22/2017Robert W DugganMajor ShareholderBuy34,728$26.25$911,610.003,054,244View SEC Filing  
5/12/2017Thierry B ThaureDirectorSell10,000$24.40$244,000.0010,000View SEC Filing  
5/11/2017Robert W DugganMajor ShareholderBuy43,389$21.04$912,904.562,984,227View SEC Filing  
5/10/2017Robert J GreenbergDirectorSell25,000$21.12$528,000.0025,000View SEC Filing  
5/8/2017Thierry B ThaureDirectorSell15,000$22.49$337,350.0015,000View SEC Filing  
4/28/2017Robert W DugganMajor ShareholderBuy84,348$23.88$2,014,230.242,958,579View SEC Filing  
4/27/2017Robert W DugganMajor ShareholderBuy35,387$24.79$877,243.732,923,379View SEC Filing  
4/19/2017Robert W DugganMajor ShareholderBuy150,123$23.77$3,568,423.712,601,850View SEC Filing  
4/18/2017Robert W DugganMajor ShareholderBuy61,819$25.49$1,575,766.312,601,850View SEC Filing  
4/17/2017Robert W DugganMajor ShareholderBuy107,300$24.81$2,662,113.002,601,850View SEC Filing  
4/10/2017Robert W. DugganMajor ShareholderBuy191,464$19.75$3,781,414.00View SEC Filing  
3/20/2017Maky ZanganehDirectorBuy18,240$23.34$425,721.60263,935View SEC Filing  
3/18/2017Robert W DugganMajor ShareholderBuy205,127$23.56$4,832,792.122,174,479View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Pulse Biosciences (NASDAQ PLSE) News Headlines

Source:
DateHeadline
BidaskClub Lowers Pulse Biosciences (PLSE) to Strong SellBidaskClub Lowers Pulse Biosciences (PLSE) to Strong Sell
www.americanbankingnews.com - February 18 at 1:00 PM
Pulse Biosciences (PLSE) Lifted to "Hold" at ValuEnginePulse Biosciences (PLSE) Lifted to "Hold" at ValuEngine
www.americanbankingnews.com - February 4 at 5:35 PM
Financial Comparison: Pulse Biosciences (PLSE) vs. Its CompetitorsFinancial Comparison: Pulse Biosciences (PLSE) vs. Its Competitors
www.americanbankingnews.com - January 31 at 11:16 AM
Critical Contrast: Pulse Biosciences (PLSE) and The CompetitionCritical Contrast: Pulse Biosciences (PLSE) and The Competition
www.americanbankingnews.com - January 31 at 11:16 AM
Pulse Biosciences Inc (PLSE) Sees Significant Decrease in Short InterestPulse Biosciences Inc (PLSE) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - January 30 at 2:44 PM
Comparing Illumina (ILMN) & Pulse Biosciences (PLSE)Comparing Illumina (ILMN) & Pulse Biosciences (PLSE)
www.americanbankingnews.com - January 29 at 5:14 PM
Pulse Biosciences (PLSE) vs. Reshape Lifesciences (RSLS) Head-To-Head ContrastPulse Biosciences (PLSE) vs. Reshape Lifesciences (RSLS) Head-To-Head Contrast
www.americanbankingnews.com - January 28 at 9:26 AM
Head to Head Survey: Pulse Biosciences (PLSE) vs. The CompetitionHead to Head Survey: Pulse Biosciences (PLSE) vs. The Competition
www.americanbankingnews.com - January 27 at 5:20 PM
Head to Head Analysis: Pulse Biosciences (PLSE) & Its RivalsHead to Head Analysis: Pulse Biosciences (PLSE) & Its Rivals
www.americanbankingnews.com - January 23 at 9:28 PM
Reviewing Pulse Biosciences (PLSE) and The CompetitionReviewing Pulse Biosciences (PLSE) and The Competition
www.americanbankingnews.com - January 20 at 7:50 PM
Pulse Biosciences (PLSE) & Its Competitors Head-To-Head ContrastPulse Biosciences (PLSE) & Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - January 17 at 5:15 PM
Pulse Biosciences (PLSE) vs. Its Peers Head-To-Head ComparisonPulse Biosciences (PLSE) vs. Its Peers Head-To-Head Comparison
www.americanbankingnews.com - January 16 at 1:10 PM
Contrasting Pulse Biosciences (PLSE) and Its PeersContrasting Pulse Biosciences (PLSE) and Its Peers
www.americanbankingnews.com - January 14 at 5:34 PM
Critical Comparison: Pulse Biosciences (PLSE) and Its CompetitorsCritical Comparison: Pulse Biosciences (PLSE) and Its Competitors
www.americanbankingnews.com - January 12 at 9:06 AM
Analyzing Pulse Biosciences (PLSE) & Its PeersAnalyzing Pulse Biosciences (PLSE) & Its Peers
www.americanbankingnews.com - January 12 at 8:04 AM
Pulse Biosciences (PLSE) & The Competition Critical AnalysisPulse Biosciences (PLSE) & The Competition Critical Analysis
www.americanbankingnews.com - January 11 at 11:46 AM
Pulse Biosciences (PLSE) and Luna Innovations (LUNA) Critical AnalysisPulse Biosciences (PLSE) and Luna Innovations (LUNA) Critical Analysis
www.americanbankingnews.com - January 10 at 9:46 AM
Head to Head Review: Pulse Biosciences (PLSE) and The CompetitionHead to Head Review: Pulse Biosciences (PLSE) and The Competition
www.americanbankingnews.com - January 9 at 11:04 AM
Pulse Biosciences (PLSE) and Its Peers Head to Head AnalysisPulse Biosciences (PLSE) and Its Peers Head to Head Analysis
www.americanbankingnews.com - January 8 at 3:30 AM
Analyzing Pulse Biosciences (PLSE) & Its CompetitorsAnalyzing Pulse Biosciences (PLSE) & Its Competitors
www.americanbankingnews.com - January 3 at 11:30 PM
Pulse Biosciences (PLSE) Upgraded to Hold at ValuEnginePulse Biosciences (PLSE) Upgraded to Hold at ValuEngine
www.americanbankingnews.com - January 1 at 12:52 PM
Biotech Forum Daily Digest: Why We Are Passing On Pulse - Seeking AlphaBiotech Forum Daily Digest: Why We Are Passing On Pulse - Seeking Alpha
seekingalpha.com - December 29 at 4:38 PM
Pulse Biosciences (PLSE) Rating Increased to Hold at BidaskClubPulse Biosciences (PLSE) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - December 29 at 8:46 AM
Pulse Biosciences (PLSE) Stock Rating Lowered by BidaskClubPulse Biosciences (PLSE) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - December 23 at 12:34 PM
Pulse Biosciences, Inc (PLSE) Short Interest Down 3.5% in NovemberPulse Biosciences, Inc (PLSE) Short Interest Down 3.5% in November
www.americanbankingnews.com - December 18 at 4:36 PM
Pulse Biosciences (PLSE) Upgraded to Hold by BidaskClubPulse Biosciences (PLSE) Upgraded to Hold by BidaskClub
www.americanbankingnews.com - December 16 at 12:02 PM
Pulse Biosciences Grants Equity Inducement Awards to New EmployeesPulse Biosciences Grants Equity Inducement Awards to New Employees
finance.yahoo.com - December 16 at 10:15 AM
Does Pulse Biosciences Inc’s (NASDAQ:PLSE) CEO Pay Reflect Performance?Does Pulse Biosciences Inc’s (NASDAQ:PLSE) CEO Pay Reflect Performance?
finance.yahoo.com - December 14 at 10:22 AM
Pulse Biosciences, Inc (PLSE) Director Acquires $92,280.00 in StockPulse Biosciences, Inc (PLSE) Director Acquires $92,280.00 in Stock
www.americanbankingnews.com - December 13 at 11:38 PM
Pulse Biosciences Quarterly Investor Conference Call - Business Wire (press release)Pulse Biosciences Quarterly Investor Conference Call - Business Wire (press release)
www.businesswire.com - November 9 at 11:39 AM
Pulse Biosciences, Inc. to Host Earnings CallPulse Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 11:39 AM
Pulse Biosciences Quarterly Investor Conference CallPulse Biosciences Quarterly Investor Conference Call
finance.yahoo.com - November 9 at 11:39 AM
Pulse Biosciences, Inc (PLSE) Issues Quarterly  Earnings ResultsPulse Biosciences, Inc (PLSE) Issues Quarterly Earnings Results
www.americanbankingnews.com - November 8 at 3:02 PM
Pulse Biosciences, Inc (PLSE) to Release Earnings on MondayPulse Biosciences, Inc (PLSE) to Release Earnings on Monday
www.americanbankingnews.com - November 6 at 2:14 AM
Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017
finance.yahoo.com - October 25 at 9:10 AM
Commit To Purchase Pulse Biosciences At $17.50, Earn 17.5% Annualized Using Options - TheStreet.comCommit To Purchase Pulse Biosciences At $17.50, Earn 17.5% Annualized Using Options - TheStreet.com
www.thestreet.com - October 24 at 8:36 AM
Insider Buying: Pulse Biosciences, Inc (PLSE) Major Shareholder Buys 22,901 Shares of StockInsider Buying: Pulse Biosciences, Inc (PLSE) Major Shareholder Buys 22,901 Shares of Stock
www.americanbankingnews.com - October 23 at 7:28 PM
Four Tampa Bay billionaires make the Forbes 400Four Tampa Bay billionaires make the Forbes 400
www.bizjournals.com - October 19 at 7:35 AM
Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE)Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE)
finance.yahoo.com - October 16 at 2:31 AM
Tracking Pre-Clinical Data in Biotech: Risk Versus Reward - PR Newswire (press release)Tracking Pre-Clinical Data in Biotech: Risk Versus Reward - PR Newswire (press release)
www.prnewswire.com - October 5 at 9:39 PM
Pulse Biosciences (PLSE) Reports $30M Private Placement of Common StockPulse Biosciences (PLSE) Reports $30M Private Placement of Common Stock
www.streetinsider.com - September 27 at 6:00 PM
Pulse Biosciences, Inc (PLSE) Major Shareholder Purchases $30,040,000.00 in StockPulse Biosciences, Inc (PLSE) Major Shareholder Purchases $30,040,000.00 in Stock
www.americanbankingnews.com - September 26 at 7:24 PM
Mid-Afternoon Market Update: Crude Oil Up Over 3%; AZZ Shares Plummet - BenzingaMid-Afternoon Market Update: Crude Oil Up Over 3%; AZZ Shares Plummet - Benzinga
www.benzinga.com - September 25 at 5:11 PM
Pulse Biosciences (PLSE) Reports $30M Private Placement of Common Stock - StreetInsider.comPulse Biosciences (PLSE) Reports $30M Private Placement of Common Stock - StreetInsider.com
www.streetinsider.com - September 25 at 5:11 PM
Pulse Biosciences Announces $30 Million Private PlacementPulse Biosciences Announces $30 Million Private Placement
finance.yahoo.com - September 25 at 11:45 AM
Pulse Biosciences, Inc (PLSE) Major Shareholder Acquires $5,886,422.48 in StockPulse Biosciences, Inc (PLSE) Major Shareholder Acquires $5,886,422.48 in Stock
www.americanbankingnews.com - September 19 at 7:26 AM
Pulse Biosciences, Inc (PLSE) Director Maky Zanganeh Buys 29,775 SharesPulse Biosciences, Inc (PLSE) Director Maky Zanganeh Buys 29,775 Shares
www.americanbankingnews.com - September 18 at 10:26 PM
Mitchell E. Levinson Purchases 3,835 Shares of Pulse Biosciences, Inc (PLSE) StockMitchell E. Levinson Purchases 3,835 Shares of Pulse Biosciences, Inc (PLSE) Stock
www.americanbankingnews.com - September 18 at 10:26 PM
Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM SystemPulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM System
finance.yahoo.com - September 13 at 7:50 AM
Mid-Day Market Update: Dow Up 1%; Achillion Pharmaceuticals Shares PlungeMid-Day Market Update: Dow Up 1%; Achillion Pharmaceuticals Shares Plunge
www.benzinga.com - September 12 at 8:39 AM

SEC Filings

Pulse Biosciences (NASDAQ:PLSE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Pulse Biosciences (NASDAQ:PLSE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Pulse Biosciences (NASDAQ PLSE) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.